Genetically modified dendritic cells – a new, promising cancer treatment strategy?

Author： Wysocki PJ Grabarczyk P Mackiewicz-Wysocka M Kowalczyk DW Mackiewicz A

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.2, Iss.8, 2002-12, pp. : 835-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetically modified dendritic cells in cancer immunotherapy: a better tomorrow?

By Shurin Michael R Gregory Melissa Morris John C Malyguine Anatoli M

Expert Opinion on Biological Therapy, Vol. 10, Iss. 11, 2010-11 ,pp. : 1539-1553

Informa Healthcare

Access to resources Recommend Favorite

A G-CSF Receptor–Gyrase B Fusion Gene: A New Type of Molecular Switch for Expansion of Genetically Modified Hematopoietic Cells

By Kume A. Ito K. Ueda Y. Hasegawa M. Urabe M. Mano H. Ozawa K.

Biochemical and Biophysical Research Communications, Vol. 260, Iss. 1, 1999-06 ,pp. : 9-12

Elsevier

Access to resources Recommend Favorite

Genetically engineered antibodies for direct antineoplastic treatment and systematic delivery of various therapeutic agents to cancer cells

By Bodey Bela

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 603-617

Informa Healthcare

Access to resources Recommend Favorite

The evolving role of dendritic cells in cancer therapy

By Ilett EJ Prestwich RJD Melcher AA

Expert Opinion on Biological Therapy, Vol. 10, Iss. 3, 2010-03 ,pp. : 369-379

Informa Healthcare

Access to resources Recommend Favorite

Dendritic cells for treatment of human malignant brain tumours

By Rainov Nikolai G Söling Ariane

Expert Opinion on Biological Therapy, Vol. 2, Iss. 3, 2002-03 ,pp. : 235-236

Informa Healthcare

Access to resources Recommend Favorite